Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]
Lario Therapeutics awarded $2.4M by The Michael J. Fox Foundation [...]
Affibody licensee Rallybio reports Phase 1 data showing sustained complement inhibition with RLYB116
Affibody has reported positive Phase 1 data from its licensee [...]
Evogene Ltd has partnered with Queensland University of Technology to [...]
Sensei Biotherapeutics has acquired Faeth Therapeutics and announced a concurrent [...]
Axol Bioscience has acquired the ophthalmology business of Newcells Biotech, [...]
Polaryx Therapeutics, Inc has selected a leading contract research organization [...]
Nuclera and leadXpro have entered a scientific partnership to develop [...]
Insilico Medicine and China Medical System Holdings Limited (CMS) have [...]
Evogene Ltd and Shanghai Lishan Biopharmaceuticals Co. have entered into [...]